Novo Nordisk NVO and Eli Lilly LLY dominate the diabetes and obesity market on the back of the tremendous success of their ...

CDSCO allows Lilly to launch weight-loss drug Mounjaro in pen format The KwikPen is a multi-dose, single-patient-use prefilled pen designed for once-in-a week administration ...

For it's latest Cintiq pen displays, Wacom combines a refined look with improved performance in multiple areas.

It comes in a prefilled pen that you’ll inject yourself with at home. Got your Wegovy pen and ready to get started? It’s time to learn how to inject Wegovy.

Novo Nordisk markets its semaglutide drugs as Ozempic pre-filled pen and Rybelsus oral tablet for type II diabetes and as Wegovy injection for weight management.

More than 90% of Omvoh-treated patients who were in clinical remission at one year sustained it with two years of continuous treatment Nearly 90% of patients who achieved endoscopic response at ...

Eli Lilly’s new products (products launched since 2022 like Ebglyss, Jaypirca, Mounjaro, Kisunla, Omvoh and Zepbound) contributed $5.64 billion to revenues, led by Mounjaro and Zepbound.

The recent U.S. Food and Drug Administration approval for Eli Lilly and Co.'s Omvoh, a new therapy to treat Chron's disease and ulcerative colitis, is the company's latest step into the treatment ...

Eli Lilly and Company LLY announced that the FDA has granted approval to its drug, Omvoh (mirikizumab), for its second inflammatory bowel disease (IBD) condition, Crohn's disease (“CD”), in the United ...